Are you a medical professional seeking to expand your knowledge about antipsychotic medications? Look no further than Stelazine - an effective drug used in the treatment of schizophrenia and other mental health disorders. In this comprehensive guide, we will unveil everything you need to know about Stelazine's pharmacokinetics, indications, contraindications, dosage regimes and potential side effects. By the end of this article, you'll have a solid foundation in understanding how to use this medication for optimal patient outcomes. So let's dive into the world of Stelazine together!
Stelazine (trifluoperazine) is an antipsychotic medication that is used to treat patients with schizophrenia. It works by helping to restore the balance of certain chemicals in the brain. Stelazine is generally well-tolerated, but it can cause some side effects, including drowsiness, dry mouth, blurred vision, and constipation.
Stelazine works by inhibiting the uptake of dopamine and serotonin in the brain. This action results in a decrease in the activity of these neurotransmitters, which leads to a reduction in the symptoms of psychosis.
The most common side effects of Stelazine are dry mouth, drowsiness, blurred vision, and constipation. Other side effects include low blood pressure, dizziness, trouble urinating, and weight gain. While most side effects are mild and manageable, some may be more serious.
Patients with a known hypersensitivity or allergy to trifluoperazine or any of its inactive ingredients should not take Stelazine. This medication is also not recommended for use in pregnant women unless the potential benefits outweigh the risks. Additionally, it is not recommended for use in children under the age of six years.
There is no generic form of Stelazine. This antipsychotic medication is only available as a brand-name drug. It's used to treat schizophrenia and other mental health disorders. If you're looking for a generic version of Stelazine, you'll need to find another medication that treats the same condition.
There are a few drugs that interact with Stelazine. These include: Tricyclic antidepressants: Stelazine may increase the effects of tricyclic antidepressants, leading to increased side effects. Monoamine oxidase inhibitors (MAOIs): Stelazine should not be used with MAOIs, as it can cause serious or life-threatening side effects. Antiarrhythmics: Stelazine may increase the risk of arrhythmias when used with antiarrhythmics. CNS depressants: Stelazine may add to the effects of CNS depressants, such as alcohol and benzodiazepines.
The antipsychotic medication Stelazine is a tricyclic antidepressant that was first approved for use in the United States in the 1950s. It is typically used to treat schizophrenia and other psychotic disorders. While Stelazine is generally considered to be safe and effective, there are some potential side effects associated with its use, including dry mouth, constipation, blurred vision, and drowsiness. In rare cases, more serious side effects such as seizures or heart problems have been reported. If you are considering using Stelazine to treat a patient, it is important to weigh the potential risks and benefits of the medication.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
2.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
3.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
4.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
5.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
1.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
2.
Exploring the Latest Treatments for Essential Thrombocythemia
3.
Colon cancer: Risk factors, warning signs and treatment options
4.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
5.
Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings- An Update
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation